High mobility group proteins in sepsis

G Liang, Z He - Frontiers in Immunology, 2022 - frontiersin.org
Sepsis, a systemic inflammatory response disease, is the most severe complication of
infection and a deadly disease. High mobility group proteins (HMGs) are non-histone …

WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer

P Wend, S Runke, K Wend, B Anchondo… - EMBO molecular …, 2013 - embopress.org
Wnt/β‐catenin signalling has been suggested to be active in basal‐like breast cancer.
However, in highly aggressive metastatic triple‐negative breast cancers (TNBC) the role of β …

Let-7a inhibits growth and migration of breast cancer cells by targeting HMGA1

K Liu, C Zhang, T Li, Y Ding, T Tu… - International …, 2015 - spandidos-publications.com
Let-7 is one of the earliest discovered microRNAs (miRNAs) and has been reported to
regulate self renewal and tumorigenicity of breast cancer cells. Let-7a is a member of this …

Extracellular HMGA1 promotes tumor invasion and metastasis in triple-negative breast cancer

O Méndez, V Peg, C Salvans, M Pujals… - Clinical Cancer …, 2018 - AACR
Purpose: The study of the cancer secretome suggests that a fraction of the intracellular
proteome could play unanticipated roles in the extracellular space during tumorigenesis. A …

HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer

F Fu, T Wang, Z Wu, Y Feng, W Wang, S Zhou… - Cell Death & …, 2018 - nature.com
High-mobility group AT-hook1 (HMGA1, formerly HMG-I/Y), an architectural transcription
factor, participates in a number of tumor biological processes. However, its effect on cervical …

SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients

GD Song, Y Sun, H Shen, W Li - Tumor Biology, 2015 - Springer
Sex-determining region Y-related high mobility group box 4 (SOX4) has been proven to
serve as a critical role in cancer development and progression. However, little is known …

Identification of proteins responsible for adriamycin resistance in breast cancer cells using proteomics analysis

Z Wang, S Liang, X Lian, L Liu, S Zhao, Q Xuan… - Scientific reports, 2015 - nature.com
Chemoresistance is a poor prognostic factor in breast cancer and is a major obstacle to the
successful treatment of patients receiving chemotherapy. However, the precise mechanism …

Linking signaling pathways to transcriptional programs in breast cancer

HU Osmanbeyoglu, R Pelossof, JF Bromberg… - Genome …, 2014 - genome.cshlp.org
Cancer cells acquire genetic and epigenetic alterations that often lead to dysregulation of
oncogenic signal transduction pathways, which in turn alters downstream transcriptional …

Development of miRNA-based PROTACs targeting Lin28 for breast cancer therapy

J Xu, X Zhao, X Liang, D Guo, J Wang, Q Wang… - Science …, 2024 - science.org
Lin28, a highly conserved carcinogenic protein, plays an important role in the generation of
cancer stem cells, contributing to the unfavorable prognosis of cancer patients. This RNA …

Dysregulated protease activated receptor 1 (PAR1) promotes metastatic phenotype in breast cancer through HMGA2

E Yang, J Cisowski, N Nguyen, K O'callaghan, J Xu… - Oncogene, 2016 - nature.com
As the majority of patients with basal-like breast carcinoma present with invasive, metastatic
disease that do not respond to available therapies, it is essential to identify new therapeutic …